Literature DB >> 16606366

Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells.

Katsutoshi Furukawa1, Michiko Matsuzaki-Kobayashi, Takafumi Hasegawa, Akio Kikuchi, Naoto Sugeno, Yasuto Itoyama, Yue Wang, Pamela J Yao, Ittai Bushlin, Atsushi Takeda.   

Abstract

Mutations in alpha-synuclein cause some cases of familial Parkinson's disease (PD), but the mechanism by which alpha-synuclein promotes degeneration of dopamine-producing neurons is unknown. We report that human neural cells expressing mutant alpha-synuclein (A30P and A53T) have higher plasma membrane ion permeability. The higher ion permeability caused by mutant alpha-synuclein would be because of relatively large pores through which most cations can pass non-selectively. Both the basal level of [Ca2+]i and the Ca2+ response to membrane depolarization are greater in cells expressing mutant alpha-synuclein. The membrane permeable Ca2+ chelator BAPTA-AM significantly protected the cells against oxidative stress, whereas neither L-type (nifedipine) nor N-type (omega-conotoxin-GVIA) Ca2+ channel blockers protected the cells. These findings suggest that the high membrane ion permeability caused by mutant alpha-synuclein may contribute to the degeneration of neurons in PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16606366     DOI: 10.1111/j.1471-4159.2006.03803.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  46 in total

1.  α-Synuclein oligomers pump it up!

Authors:  Philipp J Kahle; Naoto Sugeno; Angelos Skodras
Journal:  EMBO J       Date:  2015-09-15       Impact factor: 11.598

Review 2.  The role of lipids in α-synuclein misfolding and neurotoxicity.

Authors:  Cathryn L Ugalde; Victoria A Lawson; David I Finkelstein; Andrew F Hill
Journal:  J Biol Chem       Date:  2019-05-07       Impact factor: 5.157

Review 3.  Intrinsically disordered proteins and their environment: effects of strong denaturants, temperature, pH, counter ions, membranes, binding partners, osmolytes, and macromolecular crowding.

Authors:  Vladimir N Uversky
Journal:  Protein J       Date:  2009-10       Impact factor: 2.371

4.  Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance.

Authors:  Li Rebekah Feng; Kathleen A Maguire-Zeiss
Journal:  Neurotox Res       Date:  2011-07-07       Impact factor: 3.911

Review 5.  Antioxidant gene therapy against neuronal cell death.

Authors:  Juliana Navarro-Yepes; Laura Zavala-Flores; Annadurai Anandhan; Fang Wang; Maciej Skotak; Namas Chandra; Ming Li; Aglaia Pappa; Daniel Martinez-Fong; Luz Maria Del Razo; Betzabet Quintanilla-Vega; Rodrigo Franco
Journal:  Pharmacol Ther       Date:  2013-12-12       Impact factor: 12.310

6.  α-Synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum-mitochondria interactions.

Authors:  Tito Calì; Denis Ottolini; Alessandro Negro; Marisa Brini
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

7.  Calcium signaling and neurodegenerative diseases.

Authors:  Ilya Bezprozvanny
Journal:  Trends Mol Med       Date:  2009-02-21       Impact factor: 11.951

8.  GFAP reactivity, apolipoprotein E redistribution and cholesterol reduction in human astrocytes treated with alpha-synuclein.

Authors:  Andrew O Koob; Amy D Paulino; Eliezer Masliah
Journal:  Neurosci Lett       Date:  2009-11-20       Impact factor: 3.046

Review 9.  Molecular chaperones, α-synuclein, and neurodegeneration.

Authors:  Stephan N Witt
Journal:  Mol Neurobiol       Date:  2012-08-25       Impact factor: 5.590

Review 10.  What causes cell death in Parkinson's disease?

Authors:  Amitabh Gupta; Valina L Dawson; Ted M Dawson
Journal:  Ann Neurol       Date:  2008-12       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.